Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Biologic therapy. Chemotherapy. University of Michigan, Ann Arbor, MI, United States

Survival: 14.3 months
Toxicity Grade: 5
Treatments: Biologic therapy
Country: United States
City/State/Province: Ann Arbor, MI
Hospital: University of Michigan
Journal: Link
Date: 5/2014

This phase 2 study involved advanced urothelial carcinoma patients who were divided into two separate treatment groups. Group A consisted of 28 patients with a median age of 65.8 years and 82% were male. Group B had 60 patients with a median age of 60.9 years and 77% were male.

Patients in group A were treated with the chemotherapy agents gemcitabine and cisplatin.
Patients in group B received gemcitabine and cisplatin chemotherapy along with biologic therapy with cetuximab.

The most severe toxicities in group A were of grade 4 and included neutropenia, thrombocytopenia, and leukopenia.

Treatment-related deaths due to respiratory failure, sudden death, and heart attack were reported for group B. Grade 4 rash and neutropenia were also reported.

The median overall survival rates for groups A and B were 17.4 and 14.3 months, respectively.

This study was supported by Lilly/ImClone, makers of the study drugs.

Correspondence: Dr. Maha Hussain; email:

E-mail to a Friend Email Physician More Information